Sorry, you need to enable JavaScript to visit this website.

FELDENE® (piroxicam) Nonclinical Toxicology


13.1 Carcinogenesis, Mutagenesis, Impairment of Fertility


Long-term animal studies have not been conducted to characterize the carcinogenic potential of piroxicam.


Piroxicam was not mutagenic in an Ames bacterial reverse mutation assay, or in a dominant lethal mutation assay in mice, and was not clastogenic in an in vivo chromosome aberration assay in mice.

Impairment of Fertility

Reproductive studies in which rats were administered piroxicam at doses of 2, 5, or 10 mg/kg/day (up to 5 times the MRHD of 20 mg based on mg/m2 body surface area [BSA]) revealed no impairment of male or female fertility.

What's New

No Current Announcements.

Contact Pfizer Medical


Please enter your search term(s) for FELDENE®